CJC-1295 + Ipamorelin Blend
Also known as CJC-1295 + Ipamorelin, Mod GRF 1-29 + Ipamorelin, CJC no DAC / Ipamorelin blend
Blended GHRH and ghrelin-mimetic growth hormone secretagogue in one vial.
Medical status: Not approved as a medicine; sold as a research blend.
Also commonly used for (off-label)
- Convenient GH-support protocol from a single vial
- Sleep, recovery and body composition
- Alternative to buying CJC-1295 and Ipamorelin separately
Off-label and research uses are what people report, not approved indications. Talk to a clinician before using any of them.
How it's taken (route)
a small shot into the fat just under the skin (belly, thigh, or love handle)
New to peptides? Start with the beginner's guide.
- Documented dose
- 100–300 mcg
- Typical frequency
- 1–3 times daily, 5 days on / 2 days off
- Cycle
- 12 weeks on, 4 off
- Half-life
- ~30 minutes for CJC-1295 component; ~2 hours for Ipamorelin
- Common vial sizes
- 10 mg, 20 mg
- Regulatory status
- Not approved for human use in most jurisdictions.
Dose on a U-100 syringe (100–300 mcg)
| Vial | BAC water | Draw |
|---|---|---|
| 10 mg | 2.5 mL | 2.5–7.5 units |
| 10 mg | 3 mL | 3.0–9.0 units |
| 20 mg | 5 mL | 2.5–7.5 units |
On a U-100 syringe, 100 units = 1 mL, and the syringe holds 100 units total. Most people keep a single subcutaneous injection under about 50 units — bigger volumes are usually mixed stronger (less water) or split into two shots. Only mixes that fit in one syringe are shown. Always double-check with the reconstitution calculator.
What it does
A pre-mixed combination of CJC-1295 (no DAC) and Ipamorelin that gives two different growth hormone signals at once. CJC-1295 acts like the body's own GHRH "on" switch, while Ipamorelin mimics ghrelin to tell the pituitary to release a pulse. Together they are commonly used for deeper sleep, recovery, lean-mass support and body recomposition. What people look into it for: • Better sleep quality and overnight recovery • Gradual improvements in lean muscle and body composition • Skin, hair and connective-tissue repair • A simplified protocol from a single vial
Mechanism
CJC-1295 (no DAC) binds pituitary GHRH receptors to raise the body's natural growth hormone signal, while Ipamorelin selectively activates the ghrelin receptor (GHS-R1a) to trigger the release. The two signals work through different pathways, producing a larger, cleaner GH pulse than either peptide alone.
Storage — lyophilisedwhat's this?
Refrigerate 2-8°C, protect from light.
Storage — reconstitutedwhat's this?
Refrigerate 2-8°C, use within ~28 days.
Reconstitution noteswhat's this?
Common mix: 10 mg total peptide blend + 2.5 ml bacteriostatic water = 40 mcg per unit of each peptide when dosed as a 1:1 blend (100 mcg ≈ 3 units, 300 mcg ≈ 8 units). The same volume delivers both peptides together.
Commonly reported side effects
- Injection-site redness
- Water retention
- Head rush
- Hunger
- Drowsiness
- Tingling hands
Contraindications noted
- Active malignancy
- Pregnancy or breastfeeding
- Uncontrolled diabetes
Research notes
Best characterised when dosed on an empty stomach; frequently used as a single-vial alternative to mixing the two peptides separately.